Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2015

View Archived Issues

Novel NCSTN mutation may underlie familial hidradenitis suppurativa

Caspase-1 as a new target to prevent diabetic retinopathy

Daiichi Sankyo presents first-in-human results for DS-1040

First subject dosed in first-in-human study of ABX-1431

Summit Therapeutics' SMT-19969 receives FDA fast track designation

Novo Nordisk discontinues GLP-1 patch collaboration with Zosano

Manremyc signs Indian agreement for sale of food supplement to curb TB

Pfizer announces immunological disease collaboration

Roche and Genentech patent TYK2 kinase inhibitors

Actelion divulges new antibacterials

Gruenenthal reports development of CRAC inhibitors

Bayer Schering Pharma presents glucose transport inhibitors

Almirall reports JAK inhibitors

Merck Patent describes PDHK2 inhibitors

FDA accepts IND for trial using Viaskin Milk in milk-induced eosinophilic esophagitis

Oramed signs letter of intent for Chinese investment and licensing deal

Depomed board rejects acquisition proposal from Horizon Pharma

Tillotts acquires ex-U.S. rights to Entocort

Sernova receives funding for Cell Pouch type 1 diabetes collaboration

City of Hope launches clinical trial of immune suppression strategy in islet transplantation

Wayne State University receives grant to repurpose rosiglitazone for pre-eclampsia

Novartis starts phase II/III trial of PI3Kdelta inhibitor

Micell's sirolimus-eluting stent enters phase III trial in coronary heart disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026